Cargando…

In Vivo Therapeutic Protection against Influenza A (H1N1) Oseltamivir-Sensitive and Resistant Viruses by the Iminosugar UV-4

Our lead iminosugar analog called UV-4 or N-(9-methoxynonyl)-1-deoxynojirimycin inhibits activity of endoplasmic reticulum (ER) α-glucosidases I and II and is a potent, host-targeted antiviral candidate. The mechanism of action for the antiviral activity of iminosugars is proposed to be inhibition o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stavale, Eric J., Vu, Hong, Sampath, Aruna, Ramstedt, Urban, Warfield, Kelly L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364785/ https://www.ncbi.nlm.nih.gov/pubmed/25786028 http://dx.doi.org/10.1371/journal.pone.0121662

Ejemplares similares

A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)
por: Warfield, Kelly L., et al.
Publicado: (2015)

The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice
por: Warfield, Kelly L., et al.
Publicado: (2016)

Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects
por: Callahan, Michael, et al.
Publicado: (2022)

Iminosugars: Promising therapeutics for influenza infection
por: Tyrrell, Beatrice Ellen, et al.
Publicado: (2017)

Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
por: Warfield, Kelly L., et al.
Publicado: (2016)

Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B
por: Warfield, Kelly L., et al.
Publicado: (2019)

Iminosugars: A host-targeted approach to combat Flaviviridae infections
por: Evans DeWald, Lisa, et al.
Publicado: (2020)

Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2007)

Iminosugar antivirals: the therapeutic sweet spot
por: Alonzi, Dominic S., et al.
Publicado: (2017)

Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis
por: Esposito, Anna, et al.
Publicado: (2020)

Strain-specific antiviral activity of iminosugars against human influenza A viruses
por: Hussain, S., et al.
Publicado: (2015)

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007–08
por: Hauge, Siri H, et al.
Publicado: (2009)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2010)

Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
por: Cheng, Peter K.C., et al.
Publicado: (2009)

Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir
por: Reddy, David
Publicado: (2010)

An Amination–Cyclization Cascade Reaction for Iminosugar Synthesis Using Minimal Protecting Groups
por: Hunt-Painter, Alex A., et al.
Publicado: (2022)

Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivir
por: Dimmock, Nigel J., et al.
Publicado: (2012)

Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model
por: Miller, Joanna L., et al.
Publicado: (2016)

Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance
por: Wang, Yali, et al.
Publicado: (2022)

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir
por: Matsuzaki, Yoko, et al.
Publicado: (2010)

Oseltamivir compounding in the hospital pharmacy during the (H1N1) influenza pandemic
por: de Mário Marin, Márcia Lúcia, et al.
Publicado: (2010)

Iminosugar Amino Acid idoBR1 Reduces Inflammatory Responses in Microglia
por: Olajide, Olumayokun A., et al.
Publicado: (2022)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
por: Lee, Vernon J, et al.
Publicado: (2010)

Widespread Oseltamivir Resistance in Influenza A Viruses (H1N1), South Africa
por: Besselaar, Terry G., et al.
Publicado: (2008)

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08
por: Hauge, Siri H., et al.
Publicado: (2009)

Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
por: Kiso, Maki, et al.
Publicado: (2010)

Oseltamivir‐resistant influenza A 2009 H1N1 virus in immunocompromised patients
por: Couturier, Brianne A., et al.
Publicado: (2010)

Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus
por: Li, Yinghua, et al.
Publicado: (2017)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus
por: Miller, Joanna L., et al.
Publicado: (2018)

Oseltamivir-Resistant Influenza Viruses A (H1N1) during 2007–2009 Influenza Seasons, Japan
por: Ujike, Makoto, et al.
Publicado: (2010)

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
por: Baz, Mariana, et al.
Publicado: (2018)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2i8sic7apl3k8m5d9plshovbij